Navigation Links
Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association

LOS ANGELES (Aug. 20, 2013) Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

This lifetime achievement award was established in 2003 and is the highest honor bestowed on researchers by the association. It is the third time Bernstein has been honored by the AHA. In 2005, Bernstein was a recipient of the Novartis Prize for Hypertension Research. Two years later, he was awarded the American Heart Association's Basic Research Prize.

Bernstein formally will receive the Distinguished Scientist title at the start of the American Heart Association Scientific Sessions, Nov. 16-20, in Dallas. He will join the ranks of 75 other eminent scientists, physicians and researchers including 11 Nobel Prize recipients and Eduardo Marbn, MD, PhD, director of the Cedars-Sinai Heart Institute whose significant scientific contributions have advanced the understanding and treatment of cardiovascular disease and stroke.

"Dr. Bernstein has earned the prestigious title of Distinguished Scientist by making several important discoveries concerning the role of angiotensin converting enzyme, often called ACE, in blood pressure control, renal function, immune response and reproduction," said Shlomo Melmed, MD, senior vice president of Academic Affairs, dean of the Cedars-Sinai medical faculty and the Helene A. and Philip E. Hixon Chair in Investigative Medicine. "His work in the laboratory fuels life-saving advances in patient care. This award is a testament to the outstanding creative scholarly achievements of Dr. Bernstein."

Bernstein has studied the human body's renin-angiotensin system since 1987. This collection of enzymes plays a critical role in the control of blood pressure and in kidney function. Bernstein is recognized internationally for his cloning of the angiotensin II receptor and for his many studies of angiotensin converting enzyme, the enzyme responsible for the production of the vasoconstrictor angiotensin II.


Contact: Sally Stewart
Cedars-Sinai Medical Center

Related medicine news :

1. Kenneth Kaushansky, M.D., and David J. Kuter, M.D., D.Phil., to present 2013 Ernest Beutler Lecture
2. Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, to Speak on the Future of Medicine at the Aspen Ideas Festival in Colorado from June 26th to July 2nd, 2013
3. Westchester County Dentist Dr. Kenneth Magid, D.D.S. has been Selected for Fellowship in The International College of Dentists 2013
4. Nancy Andrews, M.D., Ph.D., and Elaine Jaffe, M.D., honored with 2013 Henry M. Stratton Medal
5. Katherine A. High, M.D., to present 2013 American Society of Hematology E. Donnall Thomas Lecture
6. BIDMCs George Tsokos, M.D., receives NIH MERIT award
7. Healdsburg District Hospital Welcomes Theresa L. Colosi, M.D., to their Orthopaedic and Total Joint Program
8. ASTRO Chairman Michael Steinberg, M.D., FASTRO, reaffirms Societys commitment to ending self-referral
9. Stephen K. Klasko, M.D., M.B.A., Named President of Thomas Jefferson University and President and CEO of TJUH System
10. Beaumont Cardiologist Kavitha Chinnaiyan, M.D., Receives Excellence in Research Award
11. Beaumont cardiologist Kavitha Chinnaiyan, M.D., receives excellence in research award
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: